APA   Click to copy
MM, S., S, T.-Z., A, B., CN, M., Costa B, K. F., U, K., … B, E.-V. (2024). Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity. HLA, 103 (6)(June). https://doi.org/10.1111

Chicago/Turabian   Click to copy
MM, Santamorena, Tischer-Zimmermann S, Bonifacius A, Mireisz CN, Khan F Costa B, Kulkarni U, Lauruschkat CD, et al. “Engineered HCMV-Infected APCs Enable the Identification of New Immunodominant HLA-Restricted Epitopes of Anti-HCMV T-Cell Immunity.” HLA 103 (6), no. June (2024).

MLA   Click to copy
MM, Santamorena, et al. “Engineered HCMV-Infected APCs Enable the Identification of New Immunodominant HLA-Restricted Epitopes of Anti-HCMV T-Cell Immunity.” HLA, vol. 103 (6), no. June, tan.15541. PMID: 38923358, 2024, doi:10.1111.

@article{santamorena2024a,
  title = {Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity},
  year = {2024},
  issue = {June},
  journal = {HLA},
  volume = {103 (6)},
  doi = {10.1111},
  author = {MM, Santamorena and S, Tischer-Zimmermann and A, Bonifacius and CN, Mireisz and Costa B, Khan F and U, Kulkarni and CD, Lauruschkat and KL, Sampaio and R, Stripecke and R, Blasczyk and B, Maecker-Kolhoff and S, Kraus and A, Schlosser and L, Cicin-Sain and U, Kalinke and B, Eiz-Vesper},
  howpublished = {tan.15541. PMID: 38923358}
}